- Home
- AMGN vs BA Comparison
AMGN vs BA Comparison
Compare AMGN & BA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMGN
- BA
- Stock Information
- Founded
- AMGN 1980
- BA 1916
- Country
- AMGN United States
- BA United States
- Employees
- AMGN N/A
- BA N/A
- Industry
- AMGN Biotechnology: Biological Products (No Diagnostic Substances)
- BA Aerospace
- Sector
- AMGN Health Care
- BA Industrials
- Exchange
- AMGN Nasdaq
- BA Nasdaq
- Market Cap
- AMGN 156.2B
- BA 129.6B
- IPO Year
- AMGN N/A
- BA N/A
- Fundamental
- Price
- AMGN $277.29
- BA $161.90
- Analyst Decision
- AMGN Buy
- BA Buy
- Analyst Count
- AMGN 20
- BA 19
- Target Price
- AMGN $324.32
- BA $198.00
- AVG Volume (30 Days)
- AMGN 3.7M
- BA 11.4M
- Earning Date
- AMGN 05-01-2025
- BA 04-23-2025
- Dividend Yield
- AMGN 3.43%
- BA N/A
- EPS Growth
- AMGN N/A
- BA N/A
- EPS
- AMGN 7.56
- BA N/A
- Revenue
- AMGN $33,424,000,000.00
- BA $66,517,000,000.00
- Revenue This Year
- AMGN $7.36
- BA $31.42
- Revenue Next Year
- AMGN $2.30
- BA $16.03
- P/E Ratio
- AMGN $36.68
- BA N/A
- Revenue Growth
- AMGN 18.57
- BA N/A
- 52 Week Low
- AMGN $253.30
- BA $128.88
- 52 Week High
- AMGN $346.85
- BA $196.95
- Technical
- Relative Strength Index (RSI)
- AMGN 36.23
- BA 50.53
- Support Level
- AMGN $267.40
- BA $153.54
- Resistance Level
- AMGN $296.17
- BA $162.55
- Average True Range (ATR)
- AMGN 12.41
- BA 8.81
- MACD
- AMGN -2.02
- BA 0.60
- Stochastic Oscillator
- AMGN 20.78
- BA 76.21
About AMGN Amgen Inc.
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
About BA Boeing Company (The)
Boeing is a major aerospace and defense firm. It operates in three segments: commercial airplanes; defense, space, and security; and global services. Boeing's commercial airplanes segment competes with Airbus in the production of aircraft that can carry more than 130 passengers. Boeing's defense, space, and security segment competes with defense contractors such as Lockheed and Northrop to create military aircraft, satellites, and weaponry. Global services provides aftermarket support to airlines.